Lyra Therapeutics Inc. (LYRA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Lyra Therapeutics Inc.

NASDAQ: LYRA · Real-Time Price · USD
6.97
-0.03 (-0.43%)
At close: Oct 03, 2025, 3:59 PM
6.93
-0.57%
After-hours: Oct 03, 2025, 04:00 PM EDT

Lyra Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
40.58M 22.35M 32.55M 45.75M
Short-Term Investments
n/a 80.4M 65.34M n/a
Long-Term Investments
1.99M 1.39M 1.39M 329K
Other Long-Term Assets
n/a 1.11M 3.28M 762K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
2.45M 2.07M 2.94M n/a
Total Current Assets
43.02M 104.82M 100.83M 47.92M
Property-Plant & Equipment
21.33M 35.28M 4.47M 5.86M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
23.32M 37.78M 9.14M 6.95M
Total Assets
66.35M 142.6M 109.97M 54.87M
Account Payables
1.18M 3.13M 2.62M 3.13M
Deferred Revenue
398K 1.66M 1.27M 9.79M
Short-Term Debt
n/a n/a 3.51M 1.07M
Other Current Liabilities
6.93M 1.23M 584K 755K
Total Current Liabilities
12.63M 19.6M 14.47M 18.25M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 14.08M 1.93M
Total Long-Term Liabilities
42.12M 33.58M 14.74M 2.31M
Total Liabilities
54.75M 53.18M 29.21M 20.55M
Total Debt
34.38M 26.88M 4.18M 1.45M
Book Value
11.59M 89.42M 80.75M 34.32M
Book Value Per Share
0.18 1.80 2.67 2.64
Common Stock
65K 57K 32K 13K
Retained Earnings
-404.79M -311.36M -248.68M -193.4M
Comprehensive Income
n/a 33K 10K n/a
Shareholders Equity
11.59M 89.42M 80.75M 34.32M
Total Investments
1.99M 80.4M 65.34M 329K